FDA Inspection 769290 — Topiderm Inc.

Topiderm Inc. — FEI 2432734

The FDA completed an inspection of Topiderm Inc. on February 24, 2012 in Amityville, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 9 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 24, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Amityville, NY (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
116221 CFR 211.28(a)Protective Apparel Not Worn
135821 CFR 211.100(b)SOPs not followed / documented
1570621 CFR 111.325(a)Laboratory operations: electronic
179021 CFR 211.80(b)Handling and Storage to Prevent Contamination
192021 CFR 211.166(a)(3)Valid stability test methods
354721 CFR 211.46(b)Equipment for Environmental Control
360321 CFR 211.160(b)Scientifically sound laboratory controls
434421 CFR 211.160(b)(1)Sampling and testing procedures described